BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heller G, Zielinski CC, Zöchbauer-Müller S. Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev 2010;29:95-107. [PMID: 20099008 DOI: 10.1007/s10555-010-9203-x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Pastuszak-Lewandoska D, Kordiak J, Migdalska-Sęk M, Czarnecka KH, Antczak A, Górski P, Nawrot E, Kiszałkiewicz JM, Domańska D, Brzeziańska-Lasota E. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients. Respir Res 2015;16:76. [PMID: 26112163 DOI: 10.1186/s12931-015-0230-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
2 Yan P, Yang X, Wang J, Wang S, Ren H. A novel CpG island methylation panel predicts survival in lung adenocarcinomas. Oncol Lett 2019;18:1011-22. [PMID: 31423161 DOI: 10.3892/ol.2019.10431] [Reference Citation Analysis]
3 Tommasi S, Zheng A, Yoon JI, Li AX, Wu X, Besaratinia A. Whole DNA methylome profiling in mice exposed to secondhand smoke. Epigenetics 2012;7:1302-14. [PMID: 23051858 DOI: 10.4161/epi.22453] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
4 Helman E, Naxerova K, Kohane IS. DNA hypermethylation in lung cancer is targeted at differentiation-associated genes. Oncogene 2012;31:1181-8. [PMID: 21804601 DOI: 10.1038/onc.2011.307] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
5 Moutinho C, Esteller M. MicroRNAs and Epigenetics. miRNA and Cancer. Elsevier; 2017. pp. 189-220. [DOI: 10.1016/bs.acr.2017.06.003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
6 Goto D, Komeda K, Uwatoko N, Nakashima M, Koike M, Kawai K, Kodama Y, Miyazawa A, Tanaka I, Hase T, Morise M, Hasegawa Y, Kawabe T, Sato M. UHRF1, a Regulator of Methylation, as a Diagnostic and Prognostic Marker for Lung Cancer. Cancer Invest 2020;38:240-9. [PMID: 32212938 DOI: 10.1080/07357907.2020.1747483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med. 2011;32:703-740. [PMID: 22054881 DOI: 10.1016/j.ccm.2011.08.003] [Cited by in Crossref: 126] [Cited by in F6Publishing: 112] [Article Influence: 11.5] [Reference Citation Analysis]
8 Pastuszak-lewandoska D, Kordiak J, Antczak A, Migdalska-sęk M, Czarnecka KH, Górski P, Nawrot E, Kiszałkiewicz JM, Domańska-senderowska D, Brzeziańska-lasota E. Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer. Med Oncol 2016;33. [DOI: 10.1007/s12032-016-0791-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
9 Heller G, Altenberger C, Schmid B, Marhold M, Tomasich E, Ziegler B, Müllauer L, Minichsdorfer C, Lang G, End-Pfützenreuter A, Döme B, Arns BM, Fong KM, Wright CM, Yang IA, Klepetko W, Zielinski CC, Zöchbauer-Müller S. DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers. Oncotarget 2015;6:394-408. [PMID: 25504438 DOI: 10.18632/oncotarget.2697] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
10 Park JY, Kim D, Yang M, Park HY, Lee SH, Rincon M, Kreahling J, Plass C, Smiraglia DJ, Tockman MS, Kim SJ. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Lung Cancer 2013;79:198-204. [PMID: 23273563 DOI: 10.1016/j.lungcan.2012.11.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
11 Feng N, Ching T, Wang Y, Liu B, Lin H, Shi O, Zhang X, Zheng M, Zheng X, Gao M, Zheng ZJ, Yu H, Garmire L, Qian B. Analysis of Microarray Data on Gene Expression and Methylation to Identify Long Non-coding RNAs in Non-small Cell Lung Cancer. Sci Rep 2016;6:37233. [PMID: 27849024 DOI: 10.1038/srep37233] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
12 Yang IV, Schwartz DA. Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med. 2011;183:1295-1301. [PMID: 21596832 DOI: 10.1164/rccm.201010-1579PP] [Cited by in Crossref: 98] [Cited by in F6Publishing: 49] [Article Influence: 8.9] [Reference Citation Analysis]
13 Opitz I, D'Amico TA, Rocco G. The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club. J Thorac Dis 2014;6 Suppl 2:S265-71. [PMID: 24868444 DOI: 10.3978/j.issn.2072-1439.2014.05.01] [Reference Citation Analysis]
14 Kadara H, Shen L, Fujimoto J, Saintigny P, Chow CW, Lang W, Chu Z, Garcia M, Kabbout M, Fan YH, Behrens C, Liu DA, Mao L, Lee JJ, Gold KA, Wang J, Coombes KR, Kim ES, Hong WK, Wistuba II. Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling. Cancer Prev Res (Phila) 2013;6:8-17. [PMID: 23087048 DOI: 10.1158/1940-6207.CAPR-12-0290] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
15 Sanders YY, Ambalavanan N, Halloran B, Zhang X, Liu H, Crossman DK, Bray M, Zhang K, Thannickal VJ, Hagood JS. Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;186:525-35. [PMID: 22700861 DOI: 10.1164/rccm.201201-0077OC] [Cited by in Crossref: 144] [Cited by in F6Publishing: 87] [Article Influence: 14.4] [Reference Citation Analysis]
16 Braga EA, Loginov VI, Pronina IV, Khodyrev DS, Rykov SV, Burdennyy AM, Friedman MV, Kazubskaya TP, Kubatiev AA, Kushlinskii NE. Upregulation of RHOA and NKIRAS1 genes in lung tumors is associated with loss of their methylation as well as with methylation of regulatory miRNA genes. Biochemistry Moscow 2015;80:483-94. [DOI: 10.1134/s0006297915040124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhang Y, Chen L. [DNA methylation and non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 2010;13:821-6. [PMID: 20704826 DOI: 10.3779/j.issn.1009-3419.2010.08.14] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Balgkouranidou I, Liloglou T, Lianidou ES. Lung cancer epigenetics: emerging biomarkers. Biomark Med 2013;7:49-58. [PMID: 23387484 DOI: 10.2217/bmm.12.111] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
19 Pasini A, Paganelli G, Tesei A, Zoli W, Giordano E, Calistri D. Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines. Transl Oncol 2012;5:461-8. [PMID: 23397475 DOI: 10.1593/tlo.12256] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
20 Jha G, Azhar S, Rashid U, Khalaf H, Alhalabi N, Ravindran D, Ahmad R. Epigenetics: The Key to Future Diagnostics and Therapeutics of Lung Cancer. Cureus 2021;13:e19770. [PMID: 34820248 DOI: 10.7759/cureus.19770] [Reference Citation Analysis]
21 Jiang ZN, Ahmed SMU, Wang QC, Shi HF, Tang XW. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival. World J Gastroenterol 2021; 27(22): 3085-3096 [PMID: 34168410 DOI: 10.3748/wjg.v27.i22.3085] [Reference Citation Analysis]
22 Altenberger C, Heller G, Ziegler B, Tomasich E, Marhold M, Topakian T, Müllauer L, Heffeter P, Lang G, End-Pfützenreuter A, Döme B, Arns BM, Klepetko W, Zielinski CC, Zöchbauer-Müller S. SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers. Mol Cancer 2017;16:1. [PMID: 28093071 DOI: 10.1186/s12943-016-0568-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 19] [Article Influence: 8.8] [Reference Citation Analysis]
23 Corrales J, Fang X, Thornton C, Mei W, Barbazuk WB, Duke M, Scheffler BE, Willett KL. Effects on specific promoter DNA methylation in zebrafish embryos and larvae following benzo[a]pyrene exposure. Comp Biochem Physiol C Toxicol Pharmacol 2014;163:37-46. [PMID: 24576477 DOI: 10.1016/j.cbpc.2014.02.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
24 Sato T, Arai E, Kohno T, Takahashi Y, Miyata S, Tsuta K, Watanabe S, Soejima K, Betsuyaku T, Kanai Y. Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease. Int J Cancer 2014;135:319-34. [PMID: 24921089 DOI: 10.1002/ijc.28684] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
25 Kumar R, Xi Y. MicroRNA, epigenetic machinery and lung cancer. Thorac Cancer 2011;2:35-44. [PMID: 27755808 DOI: 10.1111/j.1759-7714.2011.00043.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
26 Heller G, Topakian T, Altenberger C, Cerny-Reiterer S, Herndlhofer S, Ziegler B, Datlinger P, Byrgazov K, Bock C, Mannhalter C, Hörmann G, Sperr WR, Lion T, Zielinski CC, Valent P, Zöchbauer-Müller S. Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia. Leukemia 2016;30:1861-8. [PMID: 27211271 DOI: 10.1038/leu.2016.143] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
27 Powers AA, Jones KE, Eisenberg SH, Rigatti LH, Ryan JP, Luketich JD, Lotze MT, LaRue AC, Dhupar R, Soloff AC. Experimental respiratory exposure to putative Gulf War toxins promotes persistent alveolar macrophage recruitment and pulmonary inflammation. Life Sci 2021;282:119839. [PMID: 34293400 DOI: 10.1016/j.lfs.2021.119839] [Reference Citation Analysis]
28 Gu M, Dong X, Zhang X, Wang X, Qi Y, Yu J, Niu W. Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis. PLoS One. 2012;7:e37970. [PMID: 22701590 DOI: 10.1371/journal.pone.0037970] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
29 Liu K, Zhuang X, Mai Z. p73 expression is associated with cellular chemosensitivity in human non-small cell lung cancer cell lines. Oncol Lett 2013;5:583-7. [PMID: 23420689 DOI: 10.3892/ol.2012.1035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
30 Sato T, Soejima K, Arai E, Hamamoto J, Yasuda H, Arai D, Ishioka K, Ohgino K, Naoki K, Kohno T, Tsuta K, Watanabe S, Kanai Y, Betsuyaku T. Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer. Oncol Rep 2015;34:1137-45. [PMID: 26134684 DOI: 10.3892/or.2015.4082] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
31 Liu HM, Yang D, Liu ZF, Hu SZ, Yan SH, He XW. Density distribution of gene expression profiles and evaluation of using maximal information coefficient to identify differentially expressed genes. PLoS One 2019;14:e0219551. [PMID: 31314810 DOI: 10.1371/journal.pone.0219551] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Lu F, Zhang H. DNA Methylation and Nonsmall Cell Lung Cancer. Anat Rec 2011;294:1787-95. [DOI: 10.1002/ar.21471] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
33 Blair LP, Yan Q. Epigenetic mechanisms in commonly occurring cancers. DNA Cell Biol 2012;31 Suppl 1:S49-61. [PMID: 22519822 DOI: 10.1089/dna.2012.1654] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
34 Baird AM, Leonard J, Naicker KM, Kilmartin L, O'Byrne KJ, Gray SG. IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer. Lung Cancer 2013;79:83-90. [PMID: 23116756 DOI: 10.1016/j.lungcan.2012.10.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
35 Pikor LA, Ramnarine VR, Lam S, Lam WL. Genetic alterations defining NSCLC subtypes and their therapeutic implications. Lung Cancer 2013;82:179-89. [PMID: 24011633 DOI: 10.1016/j.lungcan.2013.07.025] [Cited by in Crossref: 144] [Cited by in F6Publishing: 150] [Article Influence: 16.0] [Reference Citation Analysis]
36 Heller G, Babinsky VN, Ziegler B, Weinzierl M, Noll C, Altenberger C, Müllauer L, Dekan G, Grin Y, Lang G, End-pfützenreuter A, Steiner I, Zehetmayer S, Döme B, Arns B, Fong KM, Wright CM, Yang IA, Klepetko W, Posch M, Zielinski CC, Zöchbauer-müller S. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. Carcinogenesis 2013;34:513-21. [DOI: 10.1093/carcin/bgs363] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
37 Baird AM, Gray SG, O'Byrne KJ. Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer. PLoS One 2011;6:e14593. [PMID: 21298036 DOI: 10.1371/journal.pone.0014593] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
38 Pasini A, Delmonte A, Tesei A, Calistri D, Giordano E. Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results. Drugs 2015;75:1757-71. [DOI: 10.1007/s40265-015-0461-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
39 Kadara H, Wistuba II. Field cancerization in non-small cell lung cancer: implications in disease pathogenesis. Proc Am Thorac Soc 2012;9:38-42. [PMID: 22550239 DOI: 10.1513/pats.201201-004MS] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
40 Bjaanæs MM, Fleischer T, Halvorsen AR, Daunay A, Busato F, Solberg S, Jørgensen L, Kure E, Edvardsen H, Børresen-Dale AL, Brustugun OT, Tost J, Kristensen V, Helland Å. Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis. Mol Oncol 2016;10:330-43. [PMID: 26601720 DOI: 10.1016/j.molonc.2015.10.021] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
41 Heller G, Altenberger C, Steiner I, Topakian T, Ziegler B, Tomasich E, Lang G, End-Pfützenreuter A, Zehetmayer S, Döme B, Arns BM, Klepetko W, Zielinski CC, Zöchbauer-Müller S. DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients. J Pathol 2018;245:387-98. [PMID: 29570800 DOI: 10.1002/path.5079] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
42 Kerr KM. Adenocarcinoma. In: Cagle PT, Allen TC, Beasley MB, Chirieac LR, Dacic S, Borczuk AC, Kerr KM, editors. Molecular Pathology of Lung Cancer. New York: Springer; 2012. pp. 119-62. [DOI: 10.1007/978-1-4614-3197-8_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Kadara H, Kabbout M, Wistuba II. Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology 2012;17:50-65. [PMID: 22040022 DOI: 10.1111/j.1440-1843.2011.02095.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
44 Castro M, Grau L, Puerta P, Gimenez L, Venditti J, Quadrelli S, Sánchez-Carbayo M. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med. 2010;8:86. [PMID: 20849603 DOI: 10.1186/1479-5876-8-86] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 6.3] [Reference Citation Analysis]
45 Sato T, Arai E, Kohno T, Tsuta K, Watanabe S, Soejima K, Betsuyaku T, Kanai Y. DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma. PLoS One 2013;8:e59444. [PMID: 23544068 DOI: 10.1371/journal.pone.0059444] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
46 Yang D, Liu H. Maximal information coefficient applied to differentially expressed genes identification: A feasibility study. Technol Health Care 2019;27:249-62. [PMID: 31045544 DOI: 10.3233/THC-199024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
47 Gu C, Chen C. Methylation in Lung Cancer: A Brief Review. Methods Mol Biol 2020;2204:91-7. [PMID: 32710317 DOI: 10.1007/978-1-0716-0904-0_8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
48 Fan S, Chi W. Methods for genome-wide DNA methylation analysis in human cancer. Brief Funct Genomics 2016;15:432-42. [PMID: 27056100 DOI: 10.1093/bfgp/elw010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
49 Nelson HH, Marsit CJ, Christensen BC, Houseman EA, Kontic M, Wiemels JL, Karagas MR, Wrensch MR, Zheng S, Wiencke JK. Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling. Epigenetics. 2012;7:559-566. [PMID: 22522909 DOI: 10.4161/epi.20219] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
50 Li Z, Zhang Y, Jin T, Men J, Lin Z, Qi P, Piao Y, Yan G. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. BMC Cancer. 2015;15:207. [PMID: 25880877 DOI: 10.1186/s12885-015-1227-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
51 Lee SM, Park JY, Kim DS. Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer. Mol Cells 2012;34:171-6. [PMID: 22814847 DOI: 10.1007/s10059-012-0083-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
52 Carvalho RH, Hou J, Haberle V, Aerts J, Grosveld F, Lenhard B, Philipsen S. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas. J Thorac Oncol 2013;8:562-73. [PMID: 23524404 DOI: 10.1097/JTO.0b013e3182863ed2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
53 Ponomaryova AA, Rykova EY, Cherdyntseva NV, Choinzonov EL, Laktionov PP, Vlassov VV. Molecular genetic markers in diagnosis of lung cancer. Mol Biol 2011;45:175-89. [DOI: 10.1134/s0026893310061056] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Qiu X, Qiao Y, Liu B, Li Y, You J, Zhou Q. [Advances of DNA methylation in early diagnosis of lung cancer]. Zhongguo Fei Ai Za Zhi 2012;15:234-41. [PMID: 22510510 DOI: 10.3779/j.issn.1009-3419.2012.04.08] [Reference Citation Analysis]
55 Kwon YJ, Lee SJ, Koh JS, Kim SH, Lee HW, Kang MC, Bae JB, Kim YJ, Park JH. Genome-wide analysis of DNA methylation and the gene expression change in lung cancer. J Thorac Oncol. 2012;7:20-33. [PMID: 22011669 DOI: 10.1097/jto.0b013e3182307f62] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
56 Braga EA, Khodyrev DS, Loginov VI, Pronina IV, Senchenko VN, Dmitriev AA, Kubatiev AA, Kushlinskii NE. Methylation in the regulation of the expression of chromosome 3 and microRNA genes in clear-cell renal cell carcinomas. Russ J Genet 2015;51:566-81. [DOI: 10.1134/s1022795415050026] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
57 Wen J, Fu J, Zhang W, Guo M. Genetic and epigenetic changes in lung carcinoma and their clinical implications. Mod Pathol 2011;24:932-43. [DOI: 10.1038/modpathol.2011.46] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
58 Guo S, Gao M, Li X, Li Y, Chu S, Zhu D, Niu W. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS One 2012;7:e47939. [PMID: 23110137 DOI: 10.1371/journal.pone.0047939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
59 Scesnaite A, Jarmalaite S, Mutanen P, Anttila S, Nyberg F, Benhamou S, Boffetta P, Husgafvel-Pursiainen K. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure. Mutagenesis 2012;27:423-9. [PMID: 22217548 DOI: 10.1093/mutage/ger092] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
60 Chen YS, Sun ZW, Meng CC, Tang JZ, Li XY, Wang JF, Liu L, Zhang LJ. Molecular pathogenesis and molecular targeted agents for primary liver cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(6): 914-924 [DOI: 10.11569/wcjd.v23.i6.914] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Wang H, Chen X. [Advances of DNA methylation in lung cancer]. Zhongguo Fei Ai Za Zhi 2010;13:1074-8. [PMID: 21081052 DOI: 10.3779/j.issn.1009-3419.2010.11.15] [Reference Citation Analysis]
62 O'Byrne KJ, Barr MP, Gray SG. The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer. Cancers (Basel) 2011;3:1426-53. [PMID: 24212667 DOI: 10.3390/cancers3011426] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
63 Boellmann F, Zhang L, Clewell HJ, Schroth GP, Kenyon EM, Andersen ME, Thomas RS. Genome-wide Analysis of DNA Methylation and Gene Expression Changes in the Mouse Lung following Subchronic Arsenate Exposure. Toxicological Sciences 2010;117:404-17. [DOI: 10.1093/toxsci/kfq225] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
64 Baird A, Gray SG, O’byrne KJ. IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF. European Journal of Cancer 2011;47:1908-18. [DOI: 10.1016/j.ejca.2011.04.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
65 Feng N, Wang Y, Zheng M, Yu X, Lin H, Ma R, Shi O, Zheng X, Gao M, Yu H, Garmire L, Qian B. Genome-wide analysis of DNA methylation and their associations with long noncoding RNA/mRNA expression in non-small-cell lung cancer. Epigenomics 2017;9:137-53. [DOI: 10.2217/epi-2016-0120] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
66 Langevin SM, Kratzke RA, Kelsey KT. Epigenetics of lung cancer. Transl Res 2015;165:74-90. [PMID: 24686037 DOI: 10.1016/j.trsl.2014.03.001] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 9.6] [Reference Citation Analysis]
67 Gao LM, Xu SF, Zheng Y, Wang P, Zhang L, Shi SS, Wu T, Li Y, Zhao J, Tian Q, Yin XB, Zheng L. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter. J Cell Mol Med 2019;23:6411-28. [PMID: 31317666 DOI: 10.1111/jcmm.14533] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]